Key Financial Data Of Reporting Company

Carna Biosciences, Inc. - Filing #7313273

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
Key financial data of reporting company
Business results of reporting company
Net sales
315,642,000 JPY
1,625,889,000 JPY
500,570,000 JPY
Ordinary profit (loss)
-1,087,156,000 JPY
-1,126,283,000 JPY
-868,405,000 JPY
Net assets
3,215,316,000 JPY
3,877,535,000 JPY
4,111,801,000 JPY
Total assets
3,685,650,000 JPY
4,349,891,000 JPY
4,565,118,000 JPY
Basic earnings (loss) per share
-63.25
-68.62
-53.81
Diluted earnings per share
Equity-to-asset ratio
0.872 xbrli:pure
0.891 xbrli:pure
0.899 xbrli:pure
Net cash provided by (used in) operating activities
-222,059,000 JPY
-1,677,464,000 JPY
-938,544,000 JPY
Net cash provided by (used in) investing activities
-7,108,000 JPY
-11,376,000 JPY
-6,854,000 JPY
Net cash provided by (used in) financing activities
279,068,000 JPY
1,182,027,000 JPY
1,222,158,000 JPY
Cash and cash equivalents
3,026,030,000 JPY
2,889,101,000 JPY
3,684,625,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.